A detailed history of Atalanta Sosnoff Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Atalanta Sosnoff Capital, LLC holds 138,687 shares of LLY stock, worth $106 Million. This represents 2.66% of its overall portfolio holdings.

Number of Shares
138,687
Previous 156,492 11.38%
Holding current value
$106 Million
Previous $142 Million 13.28%
% of portfolio
2.66%
Previous 3.2%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $13.7 Million - $17.1 Million
-17,805 Reduced 11.38%
138,687 $123 Million
Q2 2024

Aug 13, 2024

SELL
$724.87 - $909.04 $3.35 Million - $4.2 Million
-4,622 Reduced 2.87%
156,492 $142 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $3.6 Million - $4.81 Million
-6,076 Reduced 3.63%
161,114 $125 Million
Q4 2023

Feb 12, 2024

SELL
$525.19 - $619.13 $2.87 Million - $3.39 Million
-5,468 Reduced 3.17%
167,190 $97.5 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $21.4 Million - $29.5 Million
-49,218 Reduced 22.18%
172,658 $92.7 Million
Q2 2023

Aug 07, 2023

SELL
$350.74 - $468.98 $2.13 Million - $2.84 Million
-6,063 Reduced 2.66%
221,876 $104 Million
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $8.02 Million - $9.42 Million
25,827 Added 12.78%
227,939 $78.3 Million
Q4 2022

May 22, 2023

SELL
$321.55 - $374.67 $8.3 Million - $9.68 Million
-25,827 Reduced 11.33%
202,112 $73.9 Million
Q4 2022

Feb 09, 2023

SELL
$321.55 - $374.67 $8.59 Million - $10 Million
-26,719 Reduced 11.68%
202,112 $73.9 Million
Q3 2022

Oct 12, 2022

SELL
$296.48 - $337.87 $1.05 Million - $1.19 Million
-3,534 Reduced 1.52%
228,831 $74 Million
Q2 2022

Jul 14, 2022

BUY
$278.73 - $327.27 $21.5 Million - $25.3 Million
77,298 Added 49.85%
232,365 $75.3 Million
Q1 2022

Apr 11, 2022

BUY
$234.69 - $291.66 $1.43 Million - $1.78 Million
6,099 Added 4.09%
155,067 $44.4 Million
Q4 2021

Jan 25, 2022

BUY
$224.85 - $279.04 $57,561 - $71,434
256 Added 0.17%
148,968 $41.1 Million
Q3 2021

Oct 14, 2021

BUY
$221.6 - $272.71 $317,109 - $390,248
1,431 Added 0.97%
148,712 $34.4 Million
Q2 2021

Jul 13, 2021

SELL
$180.55 - $233.54 $259,811 - $336,064
-1,439 Reduced 0.97%
147,281 $33.8 Million
Q1 2021

Apr 20, 2021

SELL
$164.32 - $212.72 $39.2 Million - $50.8 Million
-238,584 Reduced 61.6%
148,720 $27.8 Million
Q4 2020

Jan 14, 2021

SELL
$130.46 - $172.63 $3.09 Million - $4.08 Million
-23,656 Reduced 5.76%
387,304 $65.4 Million
Q3 2020

Oct 14, 2020

SELL
$146.22 - $169.13 $1.24 Million - $1.44 Million
-8,500 Reduced 2.03%
410,960 $60.8 Million
Q2 2020

Jul 21, 2020

SELL
$136.42 - $164.18 $773,364 - $930,736
-5,669 Reduced 1.33%
419,460 $68.9 Million
Q1 2020

Apr 16, 2020

BUY
$119.05 - $147.35 $15 Million - $18.6 Million
126,054 Added 42.15%
425,129 $59 Million
Q4 2019

Jan 23, 2020

SELL
$106.92 - $132.43 $306,860 - $380,074
-2,870 Reduced 0.95%
299,075 $39.3 Million
Q3 2019

Oct 15, 2019

SELL
$106.79 - $116.16 $24.7 Million - $26.9 Million
-231,159 Reduced 43.36%
301,945 $33.8 Million
Q2 2019

Jul 15, 2019

SELL
$110.79 - $129.32 $1.86 Million - $2.18 Million
-16,821 Reduced 3.06%
533,104 $59.1 Million
Q1 2019

Apr 09, 2019

SELL
$111.31 - $131.02 $3.1 Million - $3.65 Million
-27,860 Reduced 4.82%
549,925 $71.4 Million
Q4 2018

Jan 09, 2019

BUY
$105.9 - $118.64 $23.2 Million - $26 Million
219,347 Added 61.2%
577,785 $66.9 Million
Q3 2018

Oct 10, 2018

BUY
$85.86 - $107.31 $30.8 Million - $38.5 Million
358,438 New
358,438 $38.5 Million
Q2 2018

Jul 11, 2018

SELL
$75.7 - $86.88 $1.8 Million - $2.06 Million
-23,764 Closed
0 $0
Q1 2018

Apr 06, 2018

SELL
$74.21 - $87.6 $9,350 - $11,037
-126 Reduced 0.53%
23,764 $1.84 Million
Q4 2017

Jan 09, 2018

SELL
$81.94 - $87.89 $25,729 - $27,597
-314 Reduced 1.3%
23,890 $2.02 Million
Q3 2017

Oct 10, 2017

BUY
$77.07 - $85.54 $1.87 Million - $2.07 Million
24,204
24,204 $2.07 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Atalanta Sosnoff Capital, LLC Portfolio

Follow Atalanta Sosnoff Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atalanta Sosnoff Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atalanta Sosnoff Capital, LLC with notifications on news.